Dr. Fleming Y. M. Lure received his Ph.D. degree in electrical engineering from Pennsylvania State University, State College, PA, USA, in 1990. He is a Chief Product Officer with MS Technologies Corporation, Rockville, MD, USA. His research interests include computer-aided detection (CAD), machine learning, and deep learning for disease detection, diagnosis, and prognosis on radiological images and portable devices. He has led a team to receive the first FDA pre-market approved (PMA) early-stage lung cancer detection system on radiograph. He has received more than ten SBIR/STTR Phase I/II awards from NIH and DoD to develop and commercialize computer-aided diagnosis (CAD) systems on lung cancer, tuberculosis, and Alzheimer’s disease on radiological images and fall detection from low-cost portable radar. He is also leading a team with interdisciplinary backgrounds to develop a smart imagery framing and truthing (SIFT) system to automatically annotate large amounts of COVID and tuberculosis radiographs to support various governments and consortiums to provide high-quality annotated information for the training of artificial intelligence (AI) and clinical researchers worldwide. He is a member of the Radiological Society of North America (RSNA).